Norgesic

Active Ingredient(s): Aspirin, ASA + Caffeine + Orphenadrine
FDA Approved: * March 4, 1964
Pharm Company: * 3M
Category: Muscle Relaxer

Norgesic is the brand name of a muscle relaxant produced by Medicis Pharmaceutical (currently Valeant Pharmaceuticals). The generic is a combination of 385 mg of paracetamol, 25 mg of orphenadrine citrate[1] and 30 mg of caffeine.[2] It was discontinued in the United States by the Food and Drug Administration in October 2015[3] but is still available in Scandinavia, Austria, Greece, Thailand, Australia and Hong Kong.[citation needed&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
12 Discussions

Dosage List

Norgesic 25/385/30 (Orphenadrine / Aspirin / Caffeine) Oral Tablet
NDC: 0089-0231
Labeler:
3m Pharmaceuticals
Norgesic Oral Tablet
NDC: 61825-305
Labeler:
Galt Pharmaceuticals, LLC

Related Brands

Drugs with the same active ingredients

Popular Topics

Norgesic Forte Availability

3M has discontinued making Norgesic Forte. I am trying to find out why as I have taken this medication for years? Additi...

20 REPLIES
Norgesic 35 mg

Hi, I am wondering if anyone has used Norgesic for pheriphial neurothapy? If so did you have good results?.My doctor has...

1 REPLY
manufacture of norgesic forte

do they make norgesic forte anymore ## No, I'm sorry it has been discontinued, but I haven't been able to find a...

1 REPLY
why was it discontinued norgesic forte

I get pains down my leg usually when the weather changes from warm to cold and when it rains. I have always taken Norges...

2 REPLIES
Managing Multiple Medications: My Experience with Norgesic, OxyContin, Lyrica, Antidepressants, and more.

I have been taking Norgesic for 18 months with 40mg of OxyContin 2 times daily & Lyrica 150mg as well as antidepress...

3 REPLIES
norgesic meda use

what is norgesic meda priscribed to patients for. ## Norgesic Forte is a large pill that is used for muscle spams. It wo...

1 REPLY
norgesic

answer now ## Answer what? You have not asked anything....

1 REPLY